Tirzepatide
online, legally.

The short answer

Tirzepatide is prescription-only in the United States in every form, sold as Zepbound for chronic weight management and Mounjaro for type 2 diabetes, in prefilled pens and in single-dose vials. No lawful online route skips the physician. What separates the legitimate services from the rest is simple and visible in about two minutes: a medical intake before payment, a named prescriber licensed in your state, and a named US pharmacy. The price gap between the routes is wide, and the thing you are actually buying at the higher end is someone who is accountable for the vial.

Three legal routes

• Brand through insurance — the best outcome when the plan allows it. Coverage for type 2 diabetes under the Mounjaro label is common. Coverage for weight management under Zepbound depends on the plan and usually requires prior authorization, so the first move is a call to the plan rather than to a website. With coverage the monthly number becomes a copay.
• Brand at self-pay prices, including direct vials — the manufacturer runs a direct-to-patient program that sells single-dose Zepbound vials at self-pay prices well below the pen sticker, with telehealth available to handle the prescription. This is still an approved product filled through a licensed pharmacy channel, which is exactly the part that protects you. The vial is drawn with a syringe rather than clicked from a pen, so the dosing instructions deserve real attention.
• Lawful compounded through licensed telehealth — narrower than it was, and still real for patient-specific prescriptions. Judge it by process, not by price. A physician licensed in your state must review you before you pay, and the clinic must name the US 503A or 503B pharmacy preparing your prescription. Vague answers on either point mean you are looking at a gray sale with a nicer checkout.

What ended in 2026

The enormous compounded tirzepatide market was built on the FDA shortage listing, which gave pharmacies a legal footing to make it at volume. Supply recovered, the listing ended, and through 2025 and 2026 the FDA moved against mass production and mass marketing of non-approved GLP-1 products. Narrow patient-specific compounding did not disappear, because it existed long before the shortage and rests on different ground. The catalog model did.

Plenty of sites from that era are still trading with the same page and the same flat monthly price. The offer looks unchanged, the legal basis underneath it is not, and the only way to tell from the outside is to ask who the prescriber is and which pharmacy fills it.

The 2-minute legitimacy test

Run this on any tirzepatide site before you enter a card. A service that fails the first three is not selling medicine.

• A medical intake appears before checkout, not after payment
• A physician licensed in your state is named, with a verifiable license
• The US pharmacy that fills the order is named in writing
• Brand and compounded are labeled plainly, never blurred together
• Full monthly price is shown up front, shipping included
• Price at higher doses is stated, not discovered in month three
• Labs and consult fees are listed separately, not buried
• A real medical team answers messages about side effects
• Cancellation any time, with no locked term and no penalty

The three channels

What month one looks like

Labeled dosing begins at 2.5 mg once weekly for four weeks, which is a starting dose rather than a treatment dose. It exists to let the gut adapt. From there the physician steps up at roughly monthly intervals, and each step is conditional on how the last one went.

Expect cold-chain delivery within days, written storage instructions and a follow-up already on the calendar. Expect appetite change in the first weeks and some nausea after each increase. A clinic that offers to jump you to a high dose because you asked has stopped monitoring and started selling.

Why the bill grows

Tirzepatide is priced by strength in most programs, and the dose is designed to climb. A month at the starting dose and a month at a maintenance dose are not the same product quantity, so the compounded quote that looked like the cheapest offer in month one can sit at the top of the advertised band by month four. Brand pricing behaves similarly across strengths, and savings programs and direct vial pricing change the picture again.

Ask for the price at the dose you are likely to reach, not the introductory number on the landing page. A clinic that will not publish the higher tiers before you enroll is telling you something about month three. The price index lists what US clinics currently advertise, and the cost guide shows what usually sits outside the headline figure.

Red flags that matter

• No intake before checkout, or an intake nobody could fail
• Crypto or payment-app only, with no company name attached
• Ships from overseas, or the origin is never stated at all
• Research use only wording next to human dosing advice
• Guaranteed approval, guaranteed prescription, guaranteed pounds lost
• One flat price with no mention of what higher doses cost
• Vials with no lot number, no expiry date, no storage instructions
• A twelve month package sold before any bloodwork
• The pharmacy is called trusted and partnered, but never named

Which one to ask for

If the plan covers brand, take brand. If it does not, the manufacturer self-pay vial route is the next thing to price, because it keeps an approved product and a licensed pharmacy in the chain. Lawful compounded sits below both on cost and needs the most verification from you. The comparison with the alternative molecule is a separate decision, and the head to head guide lays out the trial numbers side by side. The physician makes the final call, including the call that neither belongs in your plan.

See how the doctor path works

Questions people ask

Sources: FDA on compounded GLP-1 drugs · FDA — compounding questions and answers · PubMed — tirzepatide literature